CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

181 hedge funds and large institutions have $2.54B invested in Crinetics Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+10
Holders Change %
+5.85%
% of All Funds
2.65%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
34
Increased
75
Reduced
58
Closed
23
Calls
$22.4M
Puts
$11.9M
Net Calls
+$10.6M
Net Calls Change
+$12.5M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$144M
2
Jennison Associates
2
Jennison Associates
New York
$90.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$46.1M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$27.7M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$86M

Top Sellers

1
O
1
OrbiMed
New York
$59.3M
2
FLSM
2
Frazier Life Sciences Management
California
$14.1M
3
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$122M
5
CC
5
Commodore Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Asset Management
26
BNP Paribas Asset Management
France
$23.4M +$887K +24,925 +4%
Goldman Sachs
27
Goldman Sachs
New York
$23.1M +$3.47M +97,575 +18%
Northern Trust
28
Northern Trust
Illinois
$21.4M +$181K +5,098 +0.9%
LCM
29
Laurion Capital Management
New York
$20.2M +$7.91M +222,345 +64%
Janus Henderson Group
30
Janus Henderson Group
United Kingdom
$19.3M -$1.6M -45,115 -8%
APM
31
Avidity Partners Management
Texas
$18.8M -$2.88M -81,000 -13%
GKIM
32
GW&K Investment Management
Massachusetts
$17M -$138K -3,879 -0.8%
MB
33
MPM BioImpact
Massachusetts
$17M -$29.1K -819 -0.2%
Charles Schwab
34
Charles Schwab
California
$16.7M +$323K +9,070 +2%
VPC
35
Vestal Point Capital
New York
$16M +$16M +450,000 New
AAA
36
Affinity Asset Advisors
New York
$15.9M -$103K -2,905 -0.6%
Fisher Asset Management
37
Fisher Asset Management
Washington
$15.7M +$13.8M +387,435 +719%
Ensign Peak Advisors
38
Ensign Peak Advisors
Utah
$15.5M +$1.81M +51,000 +13%
Franklin Resources
39
Franklin Resources
California
$14.7M +$9.76M +274,384 +198%
FLSM
40
Frazier Life Sciences Management
California
$14.1M -$42.4M -1,192,448 -75%
Millennium Management
41
Millennium Management
New York
$13.3M +$3.24M +91,030 +32%
VC
42
Vivo Capital
California
$12.5M – – –
Bank of America
43
Bank of America
North Carolina
$12.3M +$6.74M +189,513 +122%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$11.7M -$5.78M -162,468 -33%
OM
45
Opaleye Management
Massachusetts
$10.9M -$2.22M -62,500 -17%
CS
46
Candriam SCA
Luxembourg
$10.2M +$10.2M +288,011 New
Walleye Capital
47
Walleye Capital
New York
$9.57M -$5.9M -165,822 -38%
SC
48
Stempoint Capital
New York
$8.88M +$8.88M +249,575 New
Rafferty Asset Management
49
Rafferty Asset Management
New York
$8.69M +$1.66M +46,548 +24%
IHAM
50
Integral Health Asset Management
New York
$7.12M – – –
1
2
3 4 5